Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae
Clinical Infectious Diseases · 08.01.2026 · 81 (Supplement_5) · S221-S222
DOI: 10.1093/cid/ciaf531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.01.2026. Verfasst von Lao-Tzu Allan-Blitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Global Health Equity: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Global Health Equity: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Lao-Tzu Allan-Blitz
Förderung
- NIAID NIH HHS
Zitieren
APA
Allan-Blitz, L. T., & Klausner, J. D. (2026). Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae. Clinical Infectious Diseases, 81(Supplement_5), S221-S222. https://doi.org/10.1093/cid/ciaf531
Vancouver
Allan-Blitz LT, Klausner JD. Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae. Clinical Infectious Diseases. 2026;81(Supplement_5):S221-S222. doi:10.1093/cid/ciaf531
BibTeX
@article{AllanBlitz2026,
author = {Allan-Blitz, Lao-Tzu and Klausner, Jeffrey D},
title = {Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {81},
number = {Supplement_5},
pages = {S221--S222},
doi = {10.1093/cid/ciaf531}
}
EUVIMED